About this fundraising
Proprietary low-cost cell culture technology "CulNet System™" as a production platformIntegral Culture Inc. has raised a total of ¥780 million through a third-party allotment of new shares to a total of 12 venture capital and operating companies, including Real Tech Fund and Future Food Fund No. 1 Investment Limited Partnership, in its Series A' round of financing. The company raised a total of 780 million yen through a third-party allotment of new shares to a total of 12 venture capital and operating companies, including Real Tech Fund and Future Food Fund No. 1 Investment Limited Partnership.
This brings the cumulative amount of funds raised to approximately 1.9 billion yen.
The funds raised will be used by a wide range of customers, from individuals to businesses.Utilized to build a cellular agricultural production platformand in FY2022,World's first mass production of cultured foie grasWe will focus on R&D and business development to bring the product to market.
Series A' Major Shareholders (titles omitted)
Real Tech Fund
Future Food Fund No.1 Investment Limited Partnership (new)
Beyond Next Ventures
Food for the Future Fund (kemuri ventures) (new)
Resona Capital No. 6 Investment Business Partnership (new)
Plan・Do・See Inc.
Yamaguchi Capital Corporation (New)
SuMi TRUST Innovation Fund (new) (*)
Iyoginko Capital (new)
AgFunder
VU Venture Partners
1 other company
(*) A private fund jointly established by Sumitomo Mitsui Trust Bank, Limited (President: Kazuya Oyama) and SBI Investment Corporation (President and CEO: Katsuya Kawashima).
Future Prospects
The funds raised this time are mainly for,Funds for the scale-up of the CulNet System, research and development to build a cell-based agricultural production platform, and commercialization of cultured foie gras products and cosmetic ingredients, etc.The funds will be allocated to Series B for the purpose of facility expansion is also planned for the second half of 2022 and beyond.
In R&D to build a cellular agriculture platform, we will broaden the range of animal species for development of culture protocols, primarily for food companies and cellular agriculture startups, and expand our contract research and collaborative research partners. in 2021.Establishment of CulNet Consortium, an open innovation platform for cellular agriculture, with 12 entitiesThe number of member companies has been increasing since then.
Released in April 2021,CELLAMENT®, a cosmetic ingredient using cell culture supernatant fluid, launched raw material sales and OEM business.The company has already received orders for raw material sales. At the 2nd Cosmetics Development Expo held in Osaka last September, more companies than expected visited the company's booth, and the company has already received orders for raw materials sales. The company plans to continue to expand its business as a raw material and OEM product, and will exhibit at COSME Week Tokyo, Japan's largest cosmetics development exhibition, to be held in January 2022.
In the food business, we will achieve the following in 2022Plans to be the first in the world to market cultured foie grasThe company will achieve stable production of 8 kg/month per machine, and then scale up production every few years to expand production scale and lower costs.
Message from Mr. Yuki Hanyu, CEO and Representative Director, Integriculture Inc.
With the funds raised this time, we will continue to pursue our mission "to provide the highest quality products and services to our customers.Creating a healthy social infrastructure by utilizing biological resources through technologyWe will continue to develop the technology for "cultured meat" and finally make cultured meat a reality in 2022. I am excited to see a world where various new food cultures will be born.
New Shareholder Message
Future Food Fund No.1 Investment Limited Partnership
Hiroshi Matsumoto, General Partner, Representative Director, Future Food Fund Co.
There are many venture companies involved in cultured meat, but Integriculture's technologyVery unique in the world, inspired by the mechanisms of living organisms.It is. We are convinced that the company's management team's ideas, technology, energy, and passion will make a significant contribution to solving the future protein crisis brought about by global population growth and environmental problems, and we look forward to their success in this field, not only in Japan. We will do our best to support them through joint research and expansion of sales channels.
Hiroki Okada, Managing Partner, Kemuri Ventures Food for the Future Fundhe
Cultured meat is an important business area that addresses issues such as "future protein source shortages" and the "global environmental impact of the livestock industry. Among othersIntegriculture is a global leader in cultured meat researchWe are convinced that the "CulNet System" developed by Integriculture will lead to a major step toward mass production of cultured meat (reduction of production costs). As a fund specializing in food tech, we will support Integriculture from both a management and business perspective.
Hidekatsu Kikuchi, President and Representative Director Resona Capital Co.he
With the recent acceleration of SDGs and decarbonization efforts, alternative meats are attracting attention as an innovation in the food sector. Integral Culture is,Innovative idea to "reproduce the human body system" in culturing meatThe company has the technology to reduce the cost of growth factors, which has been an issue in the industry, and is expected to become a leading platform in the cultured meat industry. We hope to contribute to decarbonization by supporting Integriculture's business as a financial institution through business matching with customers in Japan and overseas and by providing future financing.
Ryota Yamaguchi, Manager, Yamaguchi Capital Co.he
While global demand for food is expected to increase in the future, the livestock industry and other conventional production methods alone will face major obstacles, including supply shortages and the burden they place on the global environment. Integriculture has developedThe CulNet System is a platform technology that can break through this barrier.We decided to invest in Integriculture because we are convinced that the company's business is a good one, and we empathize with Integriculture's desire to help realize a sustainable world. The market to be challenged is very large, and we expect to make a strong impact and change the world.
Mizunori Takase, Manager, Iyogin Capital Co.he
The proprietary "CulNet System" is a cell culture technology that will directly lead to solving problems such as future protein shortages and the environmental burden caused by livestock farming, and the company will provide this technology widely as a platform,Investment attracted by high technological capabilities and coexistence-oriented management policy.I would like to thank you all for your cooperation. I am sure that there are still many obstacles to overcome before the future of cellular agriculture becomes a reality, but I believe that Integriculture Inc. has the power to overcome these obstacles and make our dreams a reality.
Michael Dean, Founding Partner, Agfunder
"The technological developments that Integriculture has achieved over the past 18 months are impressive and will make the CulNet System an industry-defining technology in the future,Confidence in promoting sustainable, high-quality protein productionThe company is doing so.
J. Skyler Fernandes, General Partner, VU Venture Partners
Integriculture's technology enables cultured meat production on a large scale and at an affordable price,Accelerated speed of commercialization of next-generation meat brandsI will do so.
【【About Integriculture]
We aim to use our proprietary low-cost cell culture technology "CulNet System™" as a new platform in the biotechnology field, which can be utilized in various fields including food products and leather, which are composed of animal cells.
CulNet System is a versatile cell culture platform technology, a device that simulates an environment that mimics organ interactions in the animal body.(patented).
This technology is theoretically capable of culturing any animal cell on a large scale and at low cost, and is envisioned for use in cultured meat and a variety of other applications. In the laboratory scale, we have already achieved the production of serum components, which had been one of the factors contributing to high costs. The realization of in-house production of serum components eliminates the use of fetal bovine serum and growth factors, which are the main causes of the high cost of conventional cell culture, and enables a significant reduction in the cost of cell culture.
■Company Profile
Company name: Integriculture Inc.
Representative Director & CEO: Yuki Hanyu
Established: October 23, 2015
Head office: 7F, 4-1-3 Hongo, Bunkyo-ku, Tokyo *Registered head office
Shinjuku Office (in Tokyo Women's Medical University): N101, TWIns 3F, 8-1 Kawada-cho, Shinjuku-ku, Tokyo
Business activities: Research and development of useful ingredients, cosmetics, foods, and cell cultured meat using the general-purpose large-scale cell culture system "CulNet System™".
WEB:https://integriculture.com/









